SEC Form 4 · accession 0001209191-16-124129
REVA Medical, Inc. · RVA:AX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
R Scott Huennekens
Director
Period of report
May 25, 2016
Accepted (ET)
May 27, 2016 · 5:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496268
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 25, 2016 | A | 6,300 | $0.00 | A | 21,300 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $8.30 | May 25, 2016 | A | 11,800 | A | — | May 25, 2026 | Common Stock | 11,800 | 11,800 | D |
Explanation of responses
- F1These restricted stock units will vest in full on the earlier of (i) May 25, 2017 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting.
- F2Twenty-five (25%) of the option shares vest on August 25, 2016, with the remaining option shares vesting in three (3) equal quarterly installments thereafter.